@article{da838d1b73c34d51b4695a5e494fb259,
title = "The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells",
author = "Johnson, {A. J.} and Yeh, {Y. Y.} and Smith, {L. L.} and Wagner, {A. J.} and J. Hessler and S. Gupta and J. Flynn and J. Jones and X. Zhang and R. Bannerji and Grever, {M. R.} and Byrd, {J. C.}",
note = "Funding Information: We thank all of the patients who donated blood for these studies and also the clinical support staff who collected them. All statistical evaluation was done by the OSU Center for Biostatistics. This work was supported by Specialized Center of Research from the Leukemia and Lymphoma Society, K12 CA133250, P50-CA140158, P01 CA95426, P01 CA8153 and P01 CA101956 from the National Cancer Institute, Pelotonia Fellowship Program and The D Warren Brown Foundation. AJJ is a Paul Calabresi Scholar and Y-YY is a Pelotonia post-doctoral fellow.",
year = "2012",
month = dec,
doi = "10.1038/leu.2012.144",
language = "English (US)",
volume = "26",
pages = "2554--2557",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "12",
}